NASDAQ: TNXPTonix Pharmaceuticals Holding Corp Stock Ownership - Who owns Tonix Pharmaceuticals Holding?
Insider buying vs selling
Have Tonix Pharmaceuticals Holding Corp insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Seth Lederman | Chief Executive Officer | 2026-03-18 | 15,000 | $14.89 | $223.35kBuy |
| Bradley Saenger | Chief Financial Officer | 2025-12-31 | 701 | $13.42 | $9.41kBuy |
| Carolyn E. Taylor | Director | 2025-08-21 | 418 | $36.03 | $15.06kBuy |
| James Treco | Director | 2025-08-20 | 250 | $36.00 | $9.00kBuy |
| Seth Lederman | Chief Executive Officer | 2025-05-15 | 4,000 | $21.55 | $86.20kBuy |
TNXP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when TNXP insiders and whales buy or sell their stock.
TNXP Shareholders
What type of owners hold Tonix Pharmaceuticals Holding Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Seth Lederman | 43.74% | 5,863,521 | $94.29M | Insider |
| Lederman Co LLC | 27.55% | 3,692,558 | $59.38M | Insider |
| David J. Moss | 24.24% | 3,250,000 | $52.26M | Insider |
| Stuart Davidson | 12.10% | 1,621,622 | $26.08M | Insider |
| Blackrock Inc | 6.60% | 884,881 | $14.23M | Institution |
| Vanguard Group Inc | 5.02% | 673,605 | $10.83M | Institution |
| Donald W. Landry | 4.91% | 658,348 | $10.59M | Insider |
| Point72 Asset Management LP | 4.63% | 620,033 | $9.97M | Institution |
| Geode Capital Management LLC | 2.03% | 271,904 | $4.37M | Institution |
| State Street Corp | 1.43% | 191,855 | $3.09M | Institution |
TNXP vs Biotech Stocks
Tonix Pharmaceuticals Holding Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.